229 related articles for article (PubMed ID: 31665449)
1. Urine Steroid Metabolomics as a Novel Tool for Detection of Recurrent Adrenocortical Carcinoma.
Chortis V; Bancos I; Nijman T; Gilligan LC; Taylor AE; Ronchi CL; O'Reilly MW; Schreiner J; Asia M; Riester A; Perotti P; Libé R; Quinkler M; Canu L; Paiva I; Bugalho MJ; Kastelan D; Dennedy MC; Sherlock M; Ambroziak U; Vassiliadi D; Bertherat J; Beuschlein F; Fassnacht M; Deeks JJ; Biehl M; Arlt W
J Clin Endocrinol Metab; 2020 Mar; 105(3):e307-18. PubMed ID: 31665449
[TBL] [Abstract][Full Text] [Related]
2. Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors.
Arlt W; Biehl M; Taylor AE; Hahner S; Libé R; Hughes BA; Schneider P; Smith DJ; Stiekema H; Krone N; Porfiri E; Opocher G; Bertherat J; Mantero F; Allolio B; Terzolo M; Nightingale P; Shackleton CH; Bertagna X; Fassnacht M; Stewart PM
J Clin Endocrinol Metab; 2011 Dec; 96(12):3775-84. PubMed ID: 21917861
[TBL] [Abstract][Full Text] [Related]
3. Different Types of Urinary Steroid Profiling Obtained by High-Performance Liquid Chromatography and Gas Chromatography-Mass Spectrometry in Patients with Adrenocortical Carcinoma.
Velikanova LI; Shafigullina ZR; Lisitsin AA; Vorokhobina NV; Grigoryan K; Kukhianidze EA; Strelnikova EG; Krivokhizhina NS; Krasnov LM; Fedorov EA; Sablin IV; Moskvin AL; Bessonova EA
Horm Cancer; 2016 Dec; 7(5-6):327-335. PubMed ID: 27370636
[TBL] [Abstract][Full Text] [Related]
4. Plasma steroid metabolome profiling for the diagnosis of adrenocortical carcinoma.
Schweitzer S; Kunz M; Kurlbaum M; Vey J; Kendl S; Deutschbein T; Hahner S; Fassnacht M; Dandekar T; Kroiss M
Eur J Endocrinol; 2019 Feb; 180(2):117-125. PubMed ID: 30481155
[TBL] [Abstract][Full Text] [Related]
5. High-Resolution, Accurate-Mass (HRAM) Mass Spectrometry Urine Steroid Profiling in the Diagnosis of Adrenal Disorders.
Hines JM; Bancos I; Bancos C; Singh RD; Avula AV; Young WF; Grebe SK; Singh RJ
Clin Chem; 2017 Dec; 63(12):1824-1835. PubMed ID: 28814383
[TBL] [Abstract][Full Text] [Related]
6. Use of urinary steroid profiling for diagnosing and monitoring adrenocortical tumours.
Tiu SC; Chan AO; Taylor NF; Lee CY; Loung PY; Choi CH; Shek CC
Hong Kong Med J; 2009 Dec; 15(6):463-70. PubMed ID: 19966352
[TBL] [Abstract][Full Text] [Related]
7. Simplified urinary steroid profiling by LC-MS as diagnostic tool for malignancy in adrenocortical tumors.
Vogg N; Müller T; Floren A; Dandekar T; Riester A; Dischinger U; Kurlbaum M; Kroiss M; Fassnacht M
Clin Chim Acta; 2023 Mar; 543():117301. PubMed ID: 36948238
[TBL] [Abstract][Full Text] [Related]
8. Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study.
Bancos I; Taylor AE; Chortis V; Sitch AJ; Jenkinson C; Davidge-Pitts CJ; Lang K; Tsagarakis S; Macech M; Riester A; Deutschbein T; Pupovac ID; Kienitz T; Prete A; Papathomas TG; Gilligan LC; Bancos C; Reimondo G; Haissaguerre M; Marina L; Grytaas MA; Sajwani A; Langton K; Ivison HE; Shackleton CHL; Erickson D; Asia M; Palimeri S; Kondracka A; Spyroglou A; Ronchi CL; Simunov B; Delivanis DA; Sutcliffe RP; Tsirou I; Bednarczuk T; Reincke M; Burger-Stritt S; Feelders RA; Canu L; Haak HR; Eisenhofer G; Dennedy MC; Ueland GA; Ivovic M; Tabarin A; Terzolo M; Quinkler M; Kastelan D; Fassnacht M; Beuschlein F; Ambroziak U; Vassiliadi DA; O'Reilly MW; Young WF; Biehl M; Deeks JJ; Arlt W;
Lancet Diabetes Endocrinol; 2020 Sep; 8(9):773-781. PubMed ID: 32711725
[TBL] [Abstract][Full Text] [Related]
9. 18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma.
Ardito A; Massaglia C; Pelosi E; Zaggia B; Basile V; Brambilla R; Vigna-Taglianti F; Duregon E; Arena V; Perotti P; Penna D; Terzolo M
Eur J Endocrinol; 2015 Dec; 173(6):749-56. PubMed ID: 26346137
[TBL] [Abstract][Full Text] [Related]
10. S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study.
Elhassan YS; Altieri B; Berhane S; Cosentini D; Calabrese A; Haissaguerre M; Kastelan D; Fragoso MCBV; Bertherat J; Al Ghuzlan A; Haak H; Boudina M; Canu L; Loli P; Sherlock M; Kimpel O; Laganà M; Sitch AJ; Kroiss M; Arlt W; Terzolo M; Berruti A; Deeks JJ; Libé R; Fassnacht M; Ronchi CL
Eur J Endocrinol; 2021 Nov; 186(1):25-36. PubMed ID: 34709200
[TBL] [Abstract][Full Text] [Related]
11. Steroid profiling in adrenal disease.
Mu D; Sun D; Qian X; Ma X; Qiu L; Cheng X; Yu S
Clin Chim Acta; 2024 Jan; 553():117749. PubMed ID: 38169194
[TBL] [Abstract][Full Text] [Related]
12. Nomograms to Predict Recurrence-Free and Overall Survival After Curative Resection of Adrenocortical Carcinoma.
Kim Y; Margonis GA; Prescott JD; Tran TB; Postlewait LM; Maithel SK; Wang TS; Evans DB; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem AI; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Poultsides GA; Pawlik TM
JAMA Surg; 2016 Apr; 151(4):365-73. PubMed ID: 26676603
[TBL] [Abstract][Full Text] [Related]
13. A 13-Steroid Serum Panel Based on LC-MS/MS: Use in Detection of Adrenocortical Carcinoma.
Taylor DR; Ghataore L; Couchman L; Vincent RP; Whitelaw B; Lewis D; Diaz-Cano S; Galata G; Schulte KM; Aylwin S; Taylor NF
Clin Chem; 2017 Dec; 63(12):1836-1846. PubMed ID: 28904054
[TBL] [Abstract][Full Text] [Related]
14. Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection.
Beuschlein F; Weigel J; Saeger W; Kroiss M; Wild V; Daffara F; Libé R; Ardito A; Al Ghuzlan A; Quinkler M; Oßwald A; Ronchi CL; de Krijger R; Feelders RA; Waldmann J; Willenberg HS; Deutschbein T; Stell A; Reincke M; Papotti M; Baudin E; Tissier F; Haak HR; Loli P; Terzolo M; Allolio B; Müller HH; Fassnacht M
J Clin Endocrinol Metab; 2015 Mar; 100(3):841-9. PubMed ID: 25559399
[TBL] [Abstract][Full Text] [Related]
15. Operative intervention for recurrence of adrenocortical carcinoma: A single-center experience.
Zhang F; Liu Z; Liang J; Tang Y; Liu S; Zhou C; Zhang F; Wu K; Lu Y; Wang X
Surgery; 2021 May; 169(5):1131-1138. PubMed ID: 33279225
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis and surgical treatment of adrenocortical carcinoma. A review of the literature and report of two cases].
Shon Ch; Mladenovski V; Petkov R; K'tev N; Mikhailov N; Gavrailov M; Trifonov D
Khirurgiia (Sofiia); 2000; 56(2):45-9. PubMed ID: 11484289
[TBL] [Abstract][Full Text] [Related]
17. Operative intervention for recurrent adrenocortical cancer.
Dy BM; Wise KB; Richards ML; Young WF; Grant CS; Bible KC; Rosedahl J; Harmsen WS; Farley DR; Thompson GB
Surgery; 2013 Dec; 154(6):1292-9; discussion 1299. PubMed ID: 24238048
[TBL] [Abstract][Full Text] [Related]
18. Adrenocortical carcinoma extending into the inferior vena cava: presentation of a 15-patient series and review of the literature.
Chiche L; Dousset B; Kieffer E; Chapuis Y
Surgery; 2006 Jan; 139(1):15-27. PubMed ID: 16364713
[TBL] [Abstract][Full Text] [Related]
19. Does laparoscopic adrenalectomy jeopardize oncologic outcomes for patients with adrenocortical carcinoma?
Cooper AB; Habra MA; Grubbs EG; Bednarski BK; Ying AK; Perrier ND; Lee JE; Aloia TA
Surg Endosc; 2013 Nov; 27(11):4026-32. PubMed ID: 23765427
[TBL] [Abstract][Full Text] [Related]
20. The role of steroid metabolome analysis for the diagnosis and follow-up of adrenocortical tumors.
Chortis V
Minerva Endocrinol; 2019 Mar; 44(1):19-24. PubMed ID: 29905434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
